Chromadex Corp Stock Return On Asset
| CDXC Stock | USD 1.64 1.34 44.97% |
Chromadex Corp fundamentals help investors to digest information that contributes to Chromadex Corp's financial success or failures. It also enables traders to predict the movement of Chromadex Stock. The fundamental analysis module provides a way to measure Chromadex Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Chromadex Corp stock.
As of June 17, 2024, Return On Assets is expected to decline to -0.09. Chromadex | Return On Asset |
Chromadex Corp Company Return On Asset Analysis
Chromadex Corp's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Chromadex Corp Return On Asset | -0.0506 |
Most of Chromadex Corp's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Chromadex Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Chromadex Return On Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Chromadex Corp is extremely important. It helps to project a fair market value of Chromadex Stock properly, considering its historical fundamentals such as Return On Asset. Since Chromadex Corp's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Chromadex Corp's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Chromadex Corp's interrelated accounts and indicators.
Click cells to compare fundamentals
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Chromadex Total Assets
Total Assets |
|
Based on the latest financial disclosure, Chromadex Corp has a Return On Asset of -0.0506. This is 99.42% lower than that of the Life Sciences Tools & Services sector and 99.79% lower than that of the Health Care industry. The return on asset for all United States stocks is 63.86% lower than that of the firm.
Chromadex Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Chromadex Corp's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Chromadex Corp could also be used in its relative valuation, which is a method of valuing Chromadex Corp by comparing valuation metrics of similar companies.Chromadex Corp is currently under evaluation in return on asset category among its peers.
Chromadex Fundamentals
| Return On Equity | -0.12 | ||||
| Return On Asset | -0.0506 | ||||
| Profit Margin | (0.04) % | ||||
| Operating Margin | (0.03) % | ||||
| Current Valuation | 201.42 M | ||||
| Shares Outstanding | 75.54 M | ||||
| Shares Owned By Insiders | 35.78 % | ||||
| Shares Owned By Institutions | 18.20 % | ||||
| Number Of Shares Shorted | 1.69 M | ||||
| Price To Earning | (19.51) X | ||||
| Price To Book | 10.19 X | ||||
| Price To Sales | 3.47 X | ||||
| Revenue | 83.57 M | ||||
| Gross Profit | 42.8 M | ||||
| EBITDA | (194 K) | ||||
| Net Income | (4.94 M) | ||||
| Cash And Equivalents | 16.87 M | ||||
| Cash Per Share | 0.25 X | ||||
| Total Debt | 3.28 M | ||||
| Debt To Equity | 0.22 % | ||||
| Current Ratio | 2.17 X | ||||
| Book Value Per Share | 0.38 X | ||||
| Cash Flow From Operations | 7.04 M | ||||
| Short Ratio | 6.98 X | ||||
| Earnings Per Share | (0.05) X | ||||
| Target Price | 6.9 | ||||
| Number Of Employees | 106 | ||||
| Beta | 1.9 | ||||
| Market Capitalization | 225.11 M | ||||
| Total Asset | 54.96 M | ||||
| Retained Earnings | (190.46 M) | ||||
| Working Capital | 28.91 M | ||||
| Current Asset | 16.55 M | ||||
| Current Liabilities | 9.59 M | ||||
| Net Asset | 54.96 M |
About Chromadex Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Chromadex Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chromadex Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chromadex Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| GM | General Motors | |
| MSFT | Microsoft | |
| CRM | Salesforce |
Additional Information and Resources on Investing in Chromadex Stock
When determining whether Chromadex Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Chromadex Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Chromadex Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Chromadex Corp Stock:Check out Chromadex Corp Piotroski F Score and Chromadex Corp Altman Z Score analysis. For information on how to trade Chromadex Stock refer to our How to Trade Chromadex Stock guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chromadex Corp. If investors know Chromadex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chromadex Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.05) | Revenue Per Share 1.108 | Quarterly Revenue Growth (0.02) | Return On Assets (0.05) | Return On Equity (0.12) |
The market value of Chromadex Corp is measured differently than its book value, which is the value of Chromadex that is recorded on the company's balance sheet. Investors also form their own opinion of Chromadex Corp's value that differs from its market value or its book value, called intrinsic value, which is Chromadex Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chromadex Corp's market value can be influenced by many factors that don't directly affect Chromadex Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chromadex Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Chromadex Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chromadex Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.